Archives of Pediatric Infectious Diseases

Published by: Kowsar

Seroepidemiological Evaluation of High-Risk Human Papillomavirus Types Among Married and Unmarried Iranian Women in Tehran, Iran

Aliakbar Abedini 1 , Abdollah Karimi 1 , * , Somayeh Shamsy 1 , Roxana Mansour Ghanaie 1 and Zari Gholinejad 1
Authors Information
1 Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: July 01, 2016, 4 (3); e37766
  • Published Online: June 18, 2016
  • Article Type: Research Article
  • Received: March 12, 2016
  • Revised: April 22, 2016
  • Accepted: May 10, 2016
  • DOI: 10.5812/pedinfect.37766

To Cite: Abedini A, Karimi A, Shamsy S, Mansour Ghanaie R, Gholinejad Z. Seroepidemiological Evaluation of High-Risk Human Papillomavirus Types Among Married and Unmarried Iranian Women in Tehran, Iran, Arch Pediatr Infect Dis. 2016 ; 4(3):e37766. doi: 10.5812/pedinfect.37766.

Copyright © 2016, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Morshed K, Polz-Gruszka D, Szymanski M, Polz-Dacewicz M. Human Papillomavirus (HPV) - structure, epidemiology and pathogenesis. Otolaryngol Pol. 2014; 68(5): 213-9[DOI][PubMed]
  • 2. Mahmoudvand S, Safaei A, Erfani N, Sarvari J. Presence of Human Papillomavirus DNA in Colorectal Cancer Tissues in Shiraz, Southwest Iran. Asian Pac J Cancer Prev. 2015; 16(17): 7883-7[PubMed]
  • 3. Gul S, Murad S, Javed A. Prevalence of High risk Human Papillomavirus in cervical dysplasia and cancer samples from twin cities in Pakistan. Int J Infect Dis. 2015; 34: 14-9[DOI][PubMed]
  • 4. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003; 16(1): 1-17[PubMed]
  • 5. Ghittoni R, Accardi R, Chiocca S, Tommasino M. Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 2015; 9: 526[DOI][PubMed]
  • 6. Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012; 33(1): 7-12[DOI][PubMed]
  • 7. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4): 244-65[PubMed]
  • 8. de Siqueira Kuperman N, Russomano FB, de Melo YLMF. Preinvasive and invasive disease in women with cytological diagnosis of high-grade lesion and high-grade lesion cannot exclude microinvasion. BMC women's health. 2015; 15(1): 1
  • 9. Shafaghi B, Jarollahi A, Yousefzadeh B, Ameri A, Moghadam S, Mostafavi M. Human Papilloma Virus Prevalence and Types among Iranian Women Attending Regular Gynecological visits. Rep Radiother Oncol. 2013; 1(2): 73-9
  • 10. Fernandes A, Bianchi G, Feltri AP, Perez M, Correnti M. Presence of human papillomavirus in breast cancer and its association with prognostic factors. Ecancermedicalscience. 2015; 9: 548[DOI][PubMed]
  • 11. Mwololo A, Nyagol J, Rogena E, Ochuk W, Kimani M, Onyango N, et al. Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva. Infect Agent Cancer. 2014; 9(1): 7[DOI][PubMed]
  • 12. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010; 11(8): 781-9[DOI][PubMed]
  • 13. Karem KL, Poon AC, Bierl C, Nisenbaum R, Unger E. Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2002; 9(3): 577-82[PubMed]
  • 14. Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, et al. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. Sex Transm Dis. 2010; 37(11): 706-14[DOI][PubMed]
  • 15. Balasubramanian A, Hughes J, Mao C, Ridder R, Herkert M, Kiviat NB, et al. Evaluation of an ELISA for p16INK4a as a screening test for cervical cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18(11): 3008-17[DOI][PubMed]
  • 16. Braaten KP, Laufer MR. Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine. Rev Obstet Gynecol. 2008; 1(1): 2-10[PubMed]
  • 17. Jalilvand S, Shoja Z, Nourijelyani K, Tohidi HR, Hamkar R. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination. J Med Virol. 2015; 87(2): 287-95[DOI][PubMed]
  • 18. Khorasanizadeh F, Hassanloo J, Khaksar N, Mohammad Taheri S, Marzaban M, Rashidi BH, et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol. 2013; 128(2): 277-81[DOI][PubMed]
  • 19. Giorgi Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, et al. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis. 2010; 10: 214[DOI][PubMed]
  • 20. Manga MM, Fowotade A, Abdullahi YM, El-Nafaty AU, Adamu DB, Pindiga HU, et al. Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria. Infect Agent Cancer. 2015; 10: 39[DOI][PubMed]
  • 21. Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, et al. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Gynecol Oncol. 2015; 137(1): 47-54[DOI][PubMed]
  • 22. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, et al. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer. 2012; 131(2): 156-61[DOI][PubMed]
  • 23. Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J. 2010; 7: 65[DOI][PubMed]
  • 24. Safaei A, Khanlari M, Momtahen M, Monabati A, Robati M, Amooei S, et al. Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J Pathol Microbiol. 2010; 53(4): 681-5[DOI][PubMed]
  • 25. Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, et al. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. PLoS One. 2013; 8(1): 53067[DOI][PubMed]
  • 26. Dillner J, Arbyn M, Unger E, Dillner L. Monitoring of human papillomavirus vaccination. Clin Exp Immunol. 2011; 163(1): 17-25[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments